Cite
The clinical efficacy and efficiency of a 100-IU starting dose of recombinant follicle stimulating hormone (Puregon[sup ®] ) in Korean women undergoingin vitro fertilization and embryo transfer.
MLA
Moon, Shin Yong, et al. “The Clinical Efficacy and Efficiency of a 100-IU Starting Dose of Recombinant Follicle Stimulating Hormone (Puregon[Sup ®] ) in Korean Women Undergoingin Vitro Fertilization and Embryo Transfer.” Journal of Obstetrics & Gynaecology Research, vol. 29, no. 3, June 2003, p. 174. EBSCOhost, https://doi.org/10.1046/j.1341-8076.2003.00096.x.
APA
Moon, S. Y., Kim, S. H., Ku, S. Y., Jee, B. C., Choi, Y. M., & Lee, J. Y. (2003). The clinical efficacy and efficiency of a 100-IU starting dose of recombinant follicle stimulating hormone (Puregon[sup ®] ) in Korean women undergoingin vitro fertilization and embryo transfer. Journal of Obstetrics & Gynaecology Research, 29(3), 174. https://doi.org/10.1046/j.1341-8076.2003.00096.x
Chicago
Moon, Shin Yong, Seok Hyun Kim, Seung Yup Ku, Byoung Chul Jee, Young Min Choi, and Jin Yong Lee. 2003. “The Clinical Efficacy and Efficiency of a 100-IU Starting Dose of Recombinant Follicle Stimulating Hormone (Puregon[Sup ®] ) in Korean Women Undergoingin Vitro Fertilization and Embryo Transfer.” Journal of Obstetrics & Gynaecology Research 29 (3): 174. doi:10.1046/j.1341-8076.2003.00096.x.